Kalmeda is a medical app offering digital Cognitive Behavioural Therapy and sound masking for chronic tinnitus management on Android.
Product velocity
Maintenance
Daily rank 🇺🇸
—
Medical
Sentiment
—
—
Nemesis
Fragmented field
The App DNA
What makes this app unique?
Patients hire Kalmeda to access structured, clinically-validated therapy that is fully covered by German statutory health insurance.
For Patients diagnosed with chronic tinnitus seeking structured, clinically-backed behavioral therapy.
What does it look like?
Key features
Structured digital exercise program for chronic tinnitus management based on clinical guidelines.
Audio files providing background masking sounds to assist with relaxation.
How much does it cost?
Monetization is anchored in the German digital health (DiGA) reimbursement model, allowing patients to access the app via prescription at no personal cost.
Velocity
Maintenance developmentperformanceopaqueShow more...
The app maintains a maintenance-level cadence, shipping approximately one release every four weeks. The latest release provides only generic stability and bug fix improvements, with no evidence of new features or live operations. Development appears focused exclusively on technical upkeep rather than functional expansion. The current release pattern has remained stable at this low-frequency pace.
Who built it?
Pohl-Boskamp Digital Health
2 apps tracked · Medical
Kalmeda Tinnitus-AppUser Sentiment
What do users think recently?
Recent user voice shows an upset sentiment. Users appreciate guided meditation and soundscapes provide relief for users struggling to manage their tinnitus symptoms.
How are ratings & reviews evolving?
What users say, by theme
- Guided meditation and soundscapes provide relief for users struggling to manage their tinnitus symptoms
- Frequent forced logouts and session timeouts disrupt the user experience during relaxation and meditation sessions
13 of 13 recent reviews analyzed · moderate confidence · Upset overall
Read the full review analysisUnlock 2 more frustration themes and 2 user requests, each backed by review evidence.
Access the full report for freeCompetition
Competitive landscape for Kalmeda Tinnitus-App
How's the Medical market?
Kalmeda holds the #4 Grossing position in the German Medical category, demonstrating strong institutional adoption via the DiGA reimbursement model. However, the 0.0 store rating across 13 reviews suggests that technical friction is currently outpacing the value of its clinical content.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for Kalmeda Tinnitus-App
Where is it heading?
The outlook for Kalmeda is declining as technical instability undermines the core therapeutic value proposition. Unless the team resolves the session-timeout issues that currently plague the latest version, the app will continue to struggle with user retention despite its strong institutional backing via the German reimbursement model.
- Frequent crashes and forced logouts during the latest version prevent therapy completion, which directly erodes the daily active habit required for clinical efficacy.
- Forced waiting periods between therapy stages are perceived as low-value barriers, which increases the risk of users abandoning the app for free public alternatives.
The SWOT
- Clinical guideline-based CBT program functions as a defensible barrier to entry against non-medical wellness apps
- Expanding accessibility features could capture the segment of tinnitus patients with physical care requirements
Next best moves
Rebuild session management to eliminate forced logouts because users report constant re-authentication prevents a smooth daily habit → increase session retention
+ 1 more prioritized moveThe counter-intuitive read
The rigid, stage-gated content delivery is likely a…
Read the full takeSince the last report: The report reflects a shift in analytical perspective, re-framing the app's restrictive content gating as a trade-off for medical certification while maintaining a focus on technical instability as the primary churn driver.
Bottom line
Kalmeda secures a unique position through its clinical reimbursement model, but technical instability and restrictive content gating actively sabotage user retention, so the team must prioritize session-persistence and stability fixes to protect the prescription-based funnel.
Unlock 1 critical friction, 1 market threat, 1 more prioritized move and the analyst’s take.
Access the full report for freeSources
Report last updated